Compare · COR vs NUS
COR vs NUS
Side-by-side comparison of Cencora Inc. (COR) and Nu Skin Enterprises Inc. (NUS): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both COR and NUS operate in Other Pharmaceuticals (Health Care), so they compete in similar markets.
- COR is the larger of the two at $51.50B, about 188.4x NUS ($273.3M).
- Over the past year, COR is down 9.4% and NUS is down 32.4% - COR leads by 23.0 points.
- Both names hit the wire about 5 times in the past 4 weeks.
- COR has more recent analyst coverage (25 ratings vs 4 for NUS).
- Company
- Cencora Inc.
- Nu Skin Enterprises Inc.
- Price
- $264.67-1.76%
- $5.63-2.60%
- Market cap
- $51.50B
- $273.3M
- 1M return
- -14.06%
- -22.88%
- 1Y return
- -9.39%
- -32.37%
- Industry
- Other Pharmaceuticals
- Other Pharmaceuticals
- Exchange
- NYSE
- NYSE
- IPO
- 1996
- News (4w)
- 5
- 5
- Recent ratings
- 25
- 4
Cencora Inc.
CoreSite Realty Corporation (NYSE:COR) delivers secure, reliable, high-performance data center, cloud access and interconnection solutions to a growing customer ecosystem across eight key North American markets. More than 1,375 of the world's leading enterprises, network operators, cloud providers, and supporting service providers choose CoreSite to connect, protect and optimize their performance-sensitive data, applications and computing workloads. Our scalable, flexible solutions and 460+ dedicated employees consistently deliver unmatched data center options  all of which leads to a best-in-class customer experience and lasting relationships.
Nu Skin Enterprises Inc.
Nu Skin Enterprises, Inc. develops and distributes personal care and wellness products worldwide. It provides skin care systems, including ageLOC Me customized skin care and ageLOC Spa systems, and ageLOC LumiSpa skin treatment and cleansing devices; and Epoch products comprising botanical ingredients derived from renewable sources, as well as a range of other cosmetic and personal care products. The company also offers ageLOC Youth nutritional supplements, ageLOC TR90 weight management and body shaping systems, and LifePak nutritional supplements, as well as other anti-aging nutritional solutions and weight management products. In addition, it is involved in the research and product development of skin care products and nutritional supplements. Further, the company operates retail stores and service centers in Mainland China. It sells its products under the Nu Skin, Pharmanex, and ageLOC brands. The company promotes and sells its products directly, as well as through distributors and Website. Nu Skin Enterprises, Inc. was founded in 1984 and is headquartered in Provo, Utah.
Latest COR
- Cencora Inc. filed SEC Form 8-K: Leadership Update, Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits
- SEC Form SD filed by Cencora Inc.
- Director Durcan Dermot Mark bought $1,065,040 worth of shares (4,000 units at $266.26), increasing direct ownership by 17% to 27,767 units (SEC Form 4)
- Cencora Appoints Eva Boratto as Executive Vice President and Chief Financial Officer
- Cencora Announces Updated Fiscal Year 2026 Financial Outlook
- SEC Form 10-Q filed by Cencora Inc.
- Cencora Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits
- Cencora Reports Fiscal 2026 Second Quarter Results
- Director Tyler Lauren M was granted 99 shares, increasing direct ownership by 3% to 3,809 units (SEC Form 4)
- Director Cooper Ellen was granted 99 shares, increasing direct ownership by 14% to 796 units (SEC Form 4)
Latest NUS
- SEC Form S-8 filed by Nu Skin Enterprises Inc.
- Nu Skin Enterprises Inc. filed SEC Form 8-K: Leadership Update, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits
- SEC Form SD filed by Nu Skin Enterprises Inc.
- Amendment: SEC Form SCHEDULE 13G/A filed by Nu Skin Enterprises Inc.
- Director Nathanson Laura sold $18,009 worth of shares (2,676 units at $6.73), decreasing direct ownership by 8% to 30,473 units (SEC Form 4)
- Nu Skin Enterprises Inc. filed SEC Form 8-K: Leadership Update
- Nu Skin Enterprises Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Nu Skin Enterprises Reports First Quarter Results
- Nu Skin Enterprises Announces Quarterly Dividend
- Nu Skin Enterprises to Announce First Quarter 2026 Financial Results